Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Critical Limb Ischemia Market?

The market size for critical limb ischemia has experienced substantial growth in the recent past. The market, valued at $3.6 billion in 2024, is projected to reach $3.9 billion in 2025, representing a compound annual growth rate (CAGR) of 8.2%. The historic growth of this market can be traced back to several factors such as the surge in diabetes instances, tobacco usage, prevalence of hypertension, advancements in vascular imaging, the rise in endovascular interventions, and ongoing medical research and clinical trials.

What Growth Rate Is Forecasted for the Critical Limb Ischemia Market by 2029?

The market size for critical limb ischemia is predicted to experience substantial expansion in the coming years. It’s projected to reach a valuation of $5.57 billion by 2029, progressing at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth for this period can be associated with advancements in regenerative medicine, an emphasis on early intervention, an escalating incidence of obesity, worldwide health drives, and patient education programs. The forecast period is expected to see prevalent trends like wearable health technology, telehealth and offsite patient tracking, the integration of artificial intelligence (AI), patient-focused care frameworks, and minimally intrusive procedures.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9859&type=smp

Which Key Companies Are Shaping the Future of the Critical Limb Ischemia Market?

Major companies operating in the critical limb ischemia market include Medtronic Plc, Boston Scientific Corporation, ThermoGenesis Holdings Inc., Abbott Laboratories, Pluri Biotech Ltd., Rexgenero Ltd., LimFlow SA, Micro Medical Solutions, Cardiovascular Systems Inc., Cynata Therapeutics Ltd, Shanghai MicroPort Medical (Group) Co Ltd., B. Braun SE, Teva Pharmaceutical Industries Ltd., Aldagen Inc., Cook Medical, Philips, BD, Penumbra Inc., Cardinal Health Inc., Teleflex Incorporated, AngioDynamics Inc., Endologix Inc., Terumo Corporation, Teleflex, MicroPort Scientific, Silk Road Medical, LeMaitre Vascular Inc., Merit Medical Systems Inc., Shockwave Medical, Avinger, Biomerics LLC, Intact Vascular Inc., Soundbite Medical Solutions, Bluegrass Vascular Technologies, PQ Bypass, Vasorum Ltd, Rex Medical, Otsuka Medical Devices, Aortica Corporation

Which Factors Are Driving Demand in the Critical Limb Ischemia Industry?

The growth of the critical limb ischemia treatment market is predicted to escalate due to the increasing incidence of diabetes mellitus and peripheral artery diseases. The former is a metabolic disease characterized by high blood glucose levels, while the latter is a health condition resulting in narrowed leg arteries, causing reduced blood flow to the legs or arms. These two diseases heighten the chances of vascular complications and amputations, subsequently leading to critical limb ischemia. Thus, their escalating incidence boosts the critical limb ischemia market’s growth. In January 2022, the International Diabetes Federation, a Belgium-based organization of national diabetes associations, projected a 12.2% (783.2 million) increase in global diabetes prevalence by 2045. Additionally, according to a March 2023 report by the Oxford University Press, a UK-based university press of the University of Oxford, the number of people suffering from peripheral artery diseases is expected to rise by almost 50% by 2045. Consequently, the expansion of the critical limb ischemia treatment market is being driven by the increasing use of cloud-based document processing services.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9859&type=smp

How Is the Critical Limb Ischemia Market Segmented by Several Divisions?

The critical limb ischemia market covered in this report is segmented –

1) By Type: Devices, Drugs, Surgery

2) By Medication: Antihypertensive Agents, Antiplatelet Drugs, Antithrombotic Agents, Other Medications

3) By Application: Hospital, Clinic, Other Applications

Subsegments:

1) By Devices: Angioplasty Balloons, Stents, Catheters, Atherectomy Devices, Implantable Devices

2) By Drugs: Antiplatelet Agents, Vasodilators, Anticoagulants, Thrombolytics, Growth Factors And Cytokines

3) By Surgery: Bypass Surgery, Endarterectomy, Amputation, Revascularization Procedures

What are the Emerging Market Trends Driving the Growth of the Critical Limb Ischemia Industry?

Top companies in the critical limb ischemia (CLI) therapy market are developing high-tech products, like bioresorbable stents, to enhance treatment results for individuals with this serious iteration of peripheral artery disease. The bioresorbable stents, otherwise referred to as dissolving stents, are devised to offer temporary reinforcement to the impacted artery, before slowly disappearing once the vessel is restored to health. For example, in April 2024, the U.S. medical device firm, Abbott Laboratories, obtained authorization from the U.S.-based federal agency, the Food and Drug Administration (FDA), for the Esprit BTK Everolimus Eluting Resorbable Scaffold System. It’s a dissolving stent geared towards patients affected by chronic limb-threatening ischemia (CLTI) in arteries below the knee. This represents the inaugural approval of a dissolving stent purposely for this ailment in the United States. Crafted from materials akin to dissolving sutures, the stent is designed to gradually disappear around three years post-implementation. The stent releases the immunosuppressive medication everolimus, which aids in preventing arteries’ re-narrowing and accelerates the healing of the vessel.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report

Which Regions Are Driving Growth in the Critical Limb Ischemia Market?

North America was the largest region in the critical limb ischemia treatment market in 2024. The regions covered in the critical limb ischemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9859

This Report Delivers Insight On:

1. How big is the critical limb ischemia market, and how is it changing globally?

2. Who are the major companies in the critical limb ischemia market, and how are they performing?

3. What are the key opportunities and risks in the critical limb ischemia market right now?

4. Which products or customer segments are growing the most in the critical limb ischemia market?

5. What factors are helping or slowing down the growth of the critical limb ischemia market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model